Cite

HARVARD Citation

    Clerk, A. et al. (n.d.). 164 Effects of Dabrafenib and Trametinib, Cancer Therapies that Target Braf and MEK, on Cardiac Signalling. Heart. pp. A94-A95. [Online]. 
  
Back to record